Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
» Aaron Lorenzo
Aaron Lorenzo
Articles
ARTICLES
Proteome Sciences Paying £12.6M For Aventis' Proteomics Division
June 5, 2002
By
Aaron Lorenzo
Alliance Gets Approval For Ultrasound Imaging Agent
June 4, 2002
By
Aaron Lorenzo
Alliance Gets Approval For Ultrasound Imaging Agent
June 4, 2002
By
Aaron Lorenzo
Proteome Sciences Paying £12.6M For Aventis' Proteomics Division
June 3, 2002
By
Aaron Lorenzo
Proteome Sciences Paying £12.6M For Aventis' Proteomics Division
June 3, 2002
By
Aaron Lorenzo
Visible Genetics Considers Sale Of Company, Lowers Estimates
May 31, 2002
By
Aaron Lorenzo
Visible Genetics Considers Sale Of Company, Lowers Estimates
May 31, 2002
By
Aaron Lorenzo
Serenex Rationalizing Proteomics To Find, Revitalize Compounds
May 29, 2002
By
Aaron Lorenzo
Serenex Rationalizing Proteomics To Find, Revitalize Compounds
May 29, 2002
By
Aaron Lorenzo
Tercica Raises $21.5M, Gains Rights To IGF-1 From Genentech
May 24, 2002
By
Aaron Lorenzo
View All Articles by Aaron Lorenzo
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
